Infantile Hemangiomas: An Emerging Health Issue Linked to an Increased Rate of Low Birth Weight Infants

2008/10/28 by Beth A. Drolet, Elizabeth A. Swanson, Ilona J. Frieden · 25 citations
Medicine · #Vascular Malformations and Hemangiomas #Tumors and Oncological Cases #Teratomas and Epidermoid Cysts

paper · doi:10.1016/j.jpeds.2008.05.043

Cited by

• Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. [europepmc]
• Incidence and clinical characteristics of periocular infantile hemangiomas. [europepmc]
• The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. [europepmc]
• Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. [europepmc]
• Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight. [europepmc]
• Prenatal Risk Factors for Infantile Hemangioma Development. [europepmc]
• Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. [europepmc]
• 15, 16-Dihydrotanshinone I Inhibits Hemangiomas through Inducing Pro-apoptotic and Anti-angiogenic Mechanisms in Vitro and in Vivo . [europepmc]
• Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma. [europepmc]
• Temporal trends in prenatal risk factors for the development of infantile hemangiomas. [europepmc]
• Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5. [europepmc]
• Vascular anomalies of the head and neck: current overview. [europepmc]
• Associations between short-term efficacy and clinical characteristics of infantile hemangioma treated by propranolol. [europepmc]
• Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review. [europepmc]
• Genetic and Environmental Risk Factors for Isolated Hemangiomas in Infants. [europepmc]
• Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls. [europepmc]
• 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1. [europepmc]
• Intraosseous Venous Malformation of the Zygomatic Bone: Comparison between Virtual Surgical Planning and Standard Surgery with Review of the Literature. [europepmc]
• Infantile Hemangiomas: An Update on Pathogenesis and Treatment. [europepmc]
• Identification of Key microRNAs and Genes in Infantile Hemangiomas. [europepmc]
• Infantile hepatic hemangiomas: looking backwards and forwards. [europepmc]
• Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size. [europepmc]
• Management of infantile hemangiomas: Recent advances. [europepmc]
• Infantile Hemangioma: A Cross-Sectional Observational Study. [europepmc]
• Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas. [europepmc]